Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antineoplastics agents > Gefitinib 184475-35-2
|Post Date:||May 07,2019|
|Expiry Date:||Nov 03,2019|
|Detailed Description:||Cas No. :184475-35-2 Gefitinib is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. However, meta-analyses have not shown any improvement in overall survival, that is, it does not extend life.|
|Company:||Shanghai Neopharm Co., Ltd. [ China ]|
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
- Atorvastatin Calcium 13452...
- D-Glucosamine Sulphate 149...
- Donepezil 120014-06-4
- Duloxetine HCL136434-34-9
- Dexamethasone Phosphate Di...
- Citicoline Sodium 33818-15...
- Clopidogrel Bisulfate 1202...
- Daptomycin 103060-53-3
- Ciprofibrate 52214-84-3
- Benserazide HCl 14919-77-8
- Celecoxib 169590-42-5
- Ciclopirox 29342-05-0
- Atropine Sulfate 55-48-1
- Benazepril Hcl 86541-74-4
- Fluazuron 86811-58-7
- Flumethrin 69770-45-2
- Imidocarb dipropionate 557...
- Iron Dextran 9004-66-4
- Levamisole Base 32093-35-9
- Florfenicol 76639-94-6
- Eprinomectin 123997-26-2
- Febantel 58306-30-2
- Fipronil 120068-37-3
- Enrofloxacin 93106-60-6
- Enrofloxacin Base 93106-60...